Joanna Smart
Director/Miembro de la Junta en Verso Biosense Group Ltd. .
Perfil
Joanna Smart is currently a Director at Verso Biosense Group Ltd.
Prior to this, she was the Executive Chairman and CEO at Oxford Cancer Biomarkers Ltd.
Cargos activos de Joanna Smart
| Empresas | Cargo | Inicio |
|---|---|---|
Verso Biosense Group Ltd.
 Verso Biosense Group Ltd. Financial ConglomeratesFinance Verso Biosense Group Ltd. is a British dormant company that was founded in 2016. The private company is based in Milton, UK. and has subsidiaries in United Kingdom. | Director/Miembro de la Junta | 09/04/2021 |
Antiguos cargos conocidos de Joanna Smart.
| Empresas | Cargo | Fin |
|---|---|---|
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Verso Biosense Group Ltd.
Verso Biosense Group Ltd. Financial ConglomeratesFinance Verso Biosense Group Ltd. is a British dormant company that was founded in 2016. The private company is based in Milton, UK. and has subsidiaries in United Kingdom. | Finance |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Bolsa de valores
- Insiders
- Joanna Smart
